Diabetic Cardiomyopathy and its Prevention by Metallothionein: Experimental Evidence, Possible Mechanisms and Clinical Implications

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|14|20|2193-2203

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.20, 2007-08, pp. : 2193-2203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SSRIs and Intraocular Pressure Modifications: Evidence, Therapeutic Implications and Possible Mechanisms

By Costagliola C.   Parmeggiani F.   Sebastiani A.  

CNS Drugs, Vol. 18, Iss. 8, 2004-01 ,pp. : 475-484

Adis International

Access to resources Recommend Favorite

Cardiac Effects of HDL and Its Components on Diabetic Cardiomyopathy

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 12, Iss. 2, 2012-06 ,pp. : 132-147

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of Restenosis with Antioxidants: Mechanisms and Implications

By Tardif J-C.   Grégoire J.   L'Allier P.L.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 5, 2002-01 ,pp. : 323-334

Adis International

Access to resources Recommend Favorite

Induction of antibodies to methadone during methadone maintenance treatment of heroin addicts and its possible clinical implications

By Gamaleya N.   Dmitrieva I.   Borg S.   Ericcson N.  

European Journal of Pharmacology, Vol. 369, Iss. 3, 1999-03 ,pp. : 357-364

Elsevier

Access to resources Recommend Favorite

Mechanisms Underlying Ventricular Arrhythmias in Idiopathic Dilated Cardiomyopathy: Implications For Management

By Merino J.L.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 2, 2001-01 ,pp. : 105-118

Adis International

Access to resources Recommend Favorite